Novel P-Selectin-Targeted Nanocarriers Enhance Drug Delivery for Medulloblastoma Treatment by Crossing the Blood-Brain Barrier
A recent study shows that P-selectin-targeted nanocarriers can effectively cross the blood-brain barrier to deliver the cancer drug vismodegib directly to medulloblastoma tumors, potentially reducing harmful side effects. Key Highlights:…